6-Methyl-1H-pyrrolo[2,3-b]pyridin-3-amine
Names and Identifiers of 1000340-30-6
CAS Number |
1000340-30-6 |
|---|---|
MDL Number |
MFCD09880119 |
IUPAC Name |
6-methyl-1H-pyrrolo[2,3-b]pyridin-3-amine |
InChI |
InChI=1S/C8H9N3/c1-5-2-3-6-7(9)4-10-8(6)11-5/h2-4H,9H2,1H3,(H,10,11) |
InChIKey |
QDZUJZCCFVJULN-UHFFFAOYSA-N |
Canonical SMILES |
CC1=NC2=C(C=C1)C(=CN2)N |
UNSPSC Code |
12352100 |
Physical and chemical properties of 1000340-30-6
Density |
1.3±0.1 g/cm3 |
|---|---|
Exact Mass |
147.079651 |
H Bond Acceptors |
2 |
H Bond Donors |
2 |
Index of Refraction |
1.737 |
LogP |
1.11 |
Molecular Formula |
C8H9N3 |
Molecular Weight |
147.177 |
PSA |
54.70000 |
Storage condition |
2-8°C |
Safety Information of 1000340-30-6
Applications of 1000340-30-6
6-Methyl-1H-pyrrolo[2,3-b]pyridin-3-amine has several applications in medicinal chemistry:
- Drug Development: Due to its inhibitory effects on FGFRs, it is being investigated for potential use in cancer therapies.
- Biochemical Research: It serves as a tool compound for studying signal transduction pathways involving FGFRs and related receptors.
Its unique structure allows for further derivatization, enhancing its potential applications in various therapeutic areas.
Interaction Studies of 1000340-30-6
Interaction studies have revealed that 6-Methyl-1H-pyrrolo[2,3-b]pyridin-3-amine binds selectively to FGFRs, influencing cellular signaling pathways critical for cancer progression. The compound's ability to modulate these interactions makes it a valuable candidate for further research in targeted therapies for malignancies associated with aberrant FGFR signaling.
Biological Activity of 1000340-30-6
This compound exhibits notable biological activity, particularly as an inhibitor of fibroblast growth factor receptors (FGFRs). FGFRs play critical roles in cellular processes such as proliferation and differentiation. Studies have shown that 6-Methyl-1H-pyrrolo[2,3-b]pyridin-3-amine can inhibit breast cancer cell proliferation and induce apoptosis through its binding interactions with FGFRs. This binding disrupts receptor dimerization and autophosphorylation, crucial steps in activating downstream signaling pathways.
